Citadel Advisors - AEVI GENOMIC MEDICINE INC ownership

AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 29 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AEVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q3 2019$24,000
+1100.0%
160,264
+994.7%
0.00%
Q2 2019$2,000
-84.6%
14,640
-77.9%
0.00%
Q1 2019$13,000
+18.2%
66,311
+320.4%
0.00%
Q4 2018$11,000
-76.6%
15,774
-58.3%
0.00%
Q3 2018$47,000
+95.8%
37,796
+214.4%
0.00%
Q1 2018$24,000
-29.4%
12,021
-57.2%
0.00%
Q4 2017$34,000
+54.5%
28,090
+62.0%
0.00%
Q3 2017$22,000
-82.0%
17,338
-73.6%
0.00%
Q1 2017$122,000
-57.3%
65,576
+18.6%
0.00%
Q4 2016$286,00055,2810.00%
Other shareholders
AEVI GENOMIC MEDICINE INC shareholders Q4 2019
NameSharesValueWeighting ↓
22NW, LP 155,000$206,0000.12%
Birchview Capital, LP 128,000$170,0000.09%
CARL DOMINO INC 43,273$58,0000.07%
NORTHERN CAPITAL MANAGEMENT LLC 106,050$141,0000.05%
ELEMENT CAPITAL MANAGEMENT LLC 124,423$165,0000.03%
Baker Brothers Advisors 1,618,089$2,152,0000.02%
SIMON QUICK ADVISORS, LLC 24,390$32,0000.02%
ARTHUR M. COHEN & ASSOCIATES, LLC 31,390$42,0000.02%
WHITE PINE CAPITAL LLC 20,000$27,0000.01%
LMR Partners LLP 112,265$149,0000.01%
View complete list of AEVI GENOMIC MEDICINE INC shareholders